"Genomic Sequencing" Category

Last month, pioneering Spokane-based and PerkinElmer-owned tech company Signature Genomic Laboratories, which provides scientific, DNA-based tests to identify genetic disorders in embryos or babies, announced they would be closing their doors sometime this summer. PerkinElmer stated that […]

$1,000 Milestone for Molecular Analysis

Posted On March 4, 2014 | by AllenCaron

In the world of molecular analysis, one long-term goal has been the creation of cost effective genome sequencing. A recent announcement from Illumina, Inc. (Nasdaq:ILMN), the world’s leading seller of gene sequencing machines, marks the near accomplishment […]

Domestic, International Small Cap Companies Work to Treat Cancer

Posted On November 12, 2013 | by AllenCaron

13% of all deaths worldwide are caused by cancer. When it comes to this disease, people are willing to try just about anything for a cure. People around the world are turning to treatments derived from things […]

The 10th anniversary of human genome sequencing recently passed, and with it, coverage of just how far we’ve come since then. Companies are getting closer and closer to cheap genome sequencing, including many small cap companies. When […]

  If you have any acquaintance with the biotech and small pharma market,  you know who Dr Elemer Piros is.  Top-ranked by the Wall Street Journal and Financial Times in different years, he is with Burrill Securities […]

The announcement that Johnson & Johnson may sell its $2.2 billion Ortho Clinical Diagnostics division for blood and cholesterol tests was no surprise to those who watch the genetics/molecular diagnostic space. Nor was it a surprise that […]

1

Subscribe to our RSS feed

Categories